Literature DB >> 10498953

Efficacy in drug receptor theory: outdated concept or under-valued tool?

T Kenakin1.   

Abstract

In classical occupancy receptor theory, efficacy is a dimensionless proportionality constant denoting the power of agonists to produce a pharmacological response. In theoretical terms, it is difficult to separate affinity and efficacy estimates of agonists for receptors, hence questioning the value of clearly flawed estimates of efficacy by conventional methods. In this paper, the use of efficacy estimates, the limitations of the current methods to estimate efficacy, and the types of systems in which serious errors in efficacy estimation would be expected, is discussed. Specifically, in constitutively active receptor systems or in those where the receptor interacts with more than one G protein, there are theoretical objections to the use of relative maximal responses as indicators of intrinsic efficacy of agonists.

Mesh:

Substances:

Year:  1999        PMID: 10498953     DOI: 10.1016/s0165-6147(99)01361-9

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  10 in total

1.  Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.

Authors:  P B Osborne; B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Quantifying ligand bias at seven-transmembrane receptors.

Authors:  Sudarshan Rajagopal; Seungkirl Ahn; David H Rominger; William Gowen-MacDonald; Christopher M Lam; Scott M Dewire; Jonathan D Violin; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2011-05-24       Impact factor: 4.436

3.  The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.

Authors:  J A Rudd; Y m Qian; K K Tsui; R L Jones
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.

Authors:  M K Mundey; A Ali; R Mason; V G Wilson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.

Authors:  Jillian G Baker; Richard G W Proudman; Christopher G Tate
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-06       Impact factor: 3.000

7.  Deducing the temporal order of cofactor function in ligand-regulated gene transcription: theory and experimental verification.

Authors:  Edward J Dougherty; Chunhua Guo; S Stoney Simons; Carson C Chow
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

Review 8.  Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor.

Authors:  Francis S Willard; Kyle W Sloop
Journal:  Exp Diabetes Res       Date:  2012-05-14

9.  The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.

Authors:  Richard G W Proudman; Juliana Akinaga; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2022-10

10.  The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2021-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.